Quick Answer
AYTU BIOPHARMA, INC reported Total Assets of $124.18 million for fiscal year 2025.
AYTU BIOPHARMA, INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $124.18M | +5.2% |
| 2024 | $118.09M | -13.5% |
| 2023 | $136.46M | -0.8% |
| 2022 | $137.62M | -48.2% |
| 2021 | $265.67M | +73.3% |
| 2020 | $153.29M | +341.5% |
| 2019 | $34.72M | +64.9% |
| 2018 | $21.06M | +40.4% |
| 2017 | $15.00M | -38.4% |
| 2016 | $24.34M | +33.6% |
| 2015 | $18.23M | +51.7% |
| 2014 | $12.02M | +124174.5% |
| 2013 | $9.7K | -23.5% |
| 2012 | $12.6K | -44.6% |
| 2011 | $22.8K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $122.00M | +5.0% | -2.4% |
| September 30, 2025 | $124.99M | +7.9% | +0.7% |
| June 30, 2025 | $124.18M | +5.2% | -0.0% |
| March 31, 2025 | $124.20M | -3.6% | +6.9% |
| December 31, 2024 | $116.23M | -11.4% | +0.3% |
| September 30, 2024 | $115.83M | -12.8% | -1.9% |
| June 30, 2024 | $118.09M | -13.5% | -8.4% |
| March 31, 2024 | $128.86M | -12.5% | -1.8% |
- AYTU BIOPHARMA, INC showed an increase of +5.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, AYTU BIOPHARMA, INC’s total assets has grown by 543629.7% (from $22.8 thousand to $124.18 million).
- The most recent figure is from AYTU BIOPHARMA, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: